cyclopentenyl cytosine has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fritzer-Szekeres, M; Gharehbaghi, K; Jayaram, HN; Szekeres, T; Zhen, W | 1 |
| Glazer, RI; Knode, MC; Lim, MI; Marquez, VE | 1 |
2 other study(ies) available for cyclopentenyl cytosine and Colonic Neoplasms
| Article | Year |
|---|---|
Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Survival; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cytidine; Cytidine Triphosphate; Dose-Response Relationship, Drug; Guanosine Triphosphate; HT29 Cells; Humans; Mice; Mice, Nude; Time Factors; Uridine Triphosphate | 1999 |
Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Colonic Neoplasms; Cytidine; Cytidine Triphosphate; Cytosine Nucleotides; DNA, Neoplasm; Humans; RNA, Neoplasm; Uridine | 1985 |